Downstream or upstream administration of P2Y12 receptor blockers in non-ST elevated acute coronary syndromes: study protocol for a randomized controlled trial

BACKGROUND: The optimal timing to administer a P2Y12 inhibitor in patients presenting with a non-ST elevation acute coronary syndrome remains a topic of debate. Pretreatment with ticagrelor before coronary anatomy is known as a widely adopted strategy. However, there is poor evidence on how this com...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarantini, Giuseppe, Mojoli, Marco, Varbella, Ferdinando, Caporale, Roberto, Rigattieri, Stefano, Andò, Giuseppe, Cirillo, Plinio, Pierini, Simona, Santarelli, Andrea, Sganzerla, Paolo, De Cesare, Nicoletta, Limbruno, Ugo, Lupi, Alessandro, Ricci, Roberto, Cernetti, Carlo, Favero, Luca, Saia, Francesco, Roncon, Loris, Gasparetto, Valeria, Ferlini, Marco, Ronco, Federico, Ferri, Luca, Trabattoni, Daniela, Russo, Alessandra, Guiducci, Vincenzo, Penzo, Carlo, Tarantino, Fabio, Mauro, Ciro, Marchese, Alfredo, Castiglioni, Battistina, La Manna, Alessio, Martinato, Matteo, Gregori, Dario, Angiolillo, Dominick J., Musumeci, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686679/
https://www.ncbi.nlm.nih.gov/pubmed/33234137
http://dx.doi.org/10.1186/s13063-020-04859-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686679/
https://www.ncbi.nlm.nih.gov/pubmed/33234137
http://dx.doi.org/10.1186/s13063-020-04859-1

Ejemplares similares